Severe iron overload in Blackfan-Diamond anemia: A case-control study

被引:47
作者
Roggero, Simona [1 ]
Quarello, Paola [2 ]
Vinciguerra, Tiziana [1 ]
Longo, Filomena [1 ]
Piga, Antonio [1 ]
Ramenghi, Ugo [2 ]
机构
[1] Univ Turin, Dept Clin & Biol Sci, I-10043 Turin, Italy
[2] Univ Turin, Dept Pediat, Hematol Unit, I-10043 Turin, Italy
关键词
DEFERASIROX ICL670; THALASSEMIA; RESONANCE; THERAPY;
D O I
10.1002/ajh.21541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic iron overload is a serious complication in transfusion-dependent patients. Few studies have addressed this issue in Diamond-Blackfan anemia (DBA). We describe a retrospective analysis of iron overload, and its related complications in 31 transfusion-dependent Italian DBA patients whose records included one or more evaluation of liver iron concentration (LIC) by means of noninvasive magnetic liver susceptometry with a superconductive quantum interference device (SQUID). This cohort is also matched with a group of transfusion-dependent beta-thalassemia major patients to look for differences. A severe iron overload was observed in 54% patients, especially among those inadequately chelated. The DBA patients displayed a significantly higher LIC than the regularly chelated beta-thalassemics. This difference may have been attributable to nonoptimal chelation (late onset, type, dose, prescription, and compliance), or an unknown biological mechanism that lead to an early severe iron overload. We therefore suggest that all transfusion patients should have an accurate record of their iron intake, a regular monitoring of iron overload, in order to start chelation when a critical transfusion load is reached, and to test the efficacy/compliance of chelation treatment. Physicians taking care of transfusion-dependent DBA patients must be concerned about the frequent and early complications such as cardiac toxicity. Am. J. Hematol. 84:729-732, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:729 / 732
页数:4
相关论文
共 24 条
[1]  
AMBRUSO DR, 1982, AM J PEDIAT HEMATOL, V4, P115
[2]   Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload [J].
Anderson, LJ ;
Holden, S ;
Davis, B ;
Prescott, E ;
Charrier, CC ;
Bunce, NH ;
Firmin, DN ;
Wonke, B ;
Porter, J ;
Walker, JM ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2001, 22 (23) :2171-2179
[3]   Hepatic iron concentration and total body iron stores in thalassemia major. [J].
Angelucci, E ;
Brittenham, GM ;
McLaren, CE ;
Ripalti, M ;
Baronciani, D ;
Giardini, C ;
Galimberti, M ;
Polchi, P ;
Lucarelli, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (05) :327-331
[4]   ENDOCRINE STUDIES IN BLACKFAN-DIAMOND ANEMIA - EVIDENCE FOR HYPOTHALAMIC-PITUITARY DYSFUNCTION UNDER FREQUENT TRANSFUSION THERAPY [J].
BECK, W ;
STUBBE, P ;
TILLMANN, W .
EUROPEAN JOURNAL OF PEDIATRICS, 1980, 135 (01) :103-105
[5]  
Campagnoli MF, 2004, HAEMATOLOGICA, V89, P480
[6]   A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia [J].
Cappellini, MD ;
Cohen, A ;
Piga, A ;
Bejaoui, M ;
Perrone, S ;
Agaoglu, L ;
Aydinok, Y ;
Kattamis, A ;
Kilinc, Y ;
Porter, J ;
Capra, M ;
Galanello, R ;
Fattoum, S ;
Drelichman, G ;
Magnano, C ;
Verissimo, M ;
Athanassiou-Metaxa, M ;
Giardina, P ;
Kourakli-Symeonidis, A ;
Janka-Schaub, G ;
Coates, T ;
Vermylen, C ;
Olivieri, N ;
Thuret, I ;
Opitz, H ;
Ressayre-Djaffer, C ;
Marks, P ;
Alberti, D .
BLOOD, 2006, 107 (09) :3455-3462
[7]  
Cappellini MD., 2008, Guidelines for the clinical management of thalassemia, V2nd
[8]   Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia [J].
Henter, Jan-Inge ;
Karlen, Jonas .
BLOOD, 2007, 109 (12) :5157-5159
[9]   Iron loading and its clinical implications [J].
Hershko, Chaim .
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (12) :1147-1148
[10]   Improving clinical care and elucidating the pathophysiology of diamond Blackfan anemia: An update from the Diamond Blackfan anemia registry [J].
Lipton, JM ;
Atsidaftos, E ;
Zyskind, I ;
Vlachos, A .
PEDIATRIC BLOOD & CANCER, 2006, 46 (05) :558-564